Gelonghui on September 19th: Yesterday, Sanuo Biotech (688117.SH), which fell more than 9%, surged to over 9% in the afternoon, and is now trading at 29.7 yuan, with a total market value of 3.33 billion yuan. The latest report from China Post Securities points out that the company has frequent bullish news, and its medium to long-term development is positive. The climbing production capacity of the company's GLP-1 active pharmaceutical ingredient, combined with the release of substantial orders, is expected to contribute substantial performance. In early September, the company proposed to invest 30 million yuan to subscribe for 22.78% equity of the target company in Tanzania, which is beneficial for further expanding the international layout of the company's peptide products. Maintain the recommendation and give a “buy” rating.